Evaxion presents preclinical data on AML vaccine candidate

🌐 Investing.com (Cyprus) —
Evaxion presents preclinical data on AML vaccine candidate

AI Summary

Evaxion has presented preclinical data on a vaccine candidate targeting acute myeloid leukemia (AML), advancing its research in immunotherapy treatments for cancer.

Health AI & Tech Evaxion AML vaccine preclinical data immunotherapy cancer research vaccine development

Read original source →